Kodiak Sciences (KOD) Total Non-Current Liabilities (2017 - 2026)

Kodiak Sciences (KOD) reported Total Non-Current Liabilities of $93.9 million for Q1 2026, up 5.43% on a YoY basis from $89.1 million in Q1 2025, and little changed quarter-over-quarter from $94.1 million in Q4 2025.

Kodiak Sciences (KOD) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

Kodiak Sciences has reported Total Non-Current Liabilities for 10 years, with the latest figure at $93.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities rose 5.43% year-over-year to $93.9 million; the trailing twelve-month figure through Mar 2026 stood at $93.9 million (up 5.43% YoY), and the FY2025 full-year result was $94.1 million, up 10.39% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $93.9 million, roughly flat from $94.1 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $251.2 million in Q2 2023, with the low at $85.3 million in Q4 2024.
  • Historically, Total Non-Current Liabilities has averaged $132.2 million across 5 years, with a median of $94.4 million in 2025.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities jumped 85.12% — and 2024, when it slumped 65.33%.
  • Kodiak Sciences' Total Non-Current Liabilities stood at $230.3 million in 2022, then sank by 50.68% to $113.6 million in 2023, then slipped by 24.91% to $85.3 million in 2024, then grew by 10.39% to $94.1 million in 2025, then fell by 0.26% to $93.9 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $93.9 million (Q1 2026), $94.1 million (Q4 2025), and $94.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 42,980.09
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 11.03 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 644,700.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.71 Bn 91.71 Bn - 64.76 Mn
10 Kodiak Sciences 1.95 Bn 1.95 Bn - 93.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 93.91 Mn
Dec 31, 2025 94.15 Mn
Sep 30, 2025 94.38 Mn
Jun 30, 2025 86.44 Mn
Mar 31, 2025 89.07 Mn
Dec 31, 2024 85.29 Mn
Sep 30, 2024 87.30 Mn
Jun 30, 2024 87.07 Mn
Mar 31, 2024 93.57 Mn
Dec 31, 2023 113.59 Mn
Sep 30, 2023 145.24 Mn
Jun 30, 2023 251.18 Mn
Mar 31, 2023 147.75 Mn
Dec 31, 2022 230.30 Mn
Sep 30, 2022 244.28 Mn
Jun 30, 2022 151.01 Mn
Mar 31, 2022 152.95 Mn
Dec 31, 2021 240.69 Mn
Sep 30, 2021 131.96 Mn
Jun 30, 2021 118.26 Mn